As part of this specialist training he completed a PhD in genetic susceptibility to cancer. He has been a consultant medical oncologist at the Christie Hospital, Manchester since October 2010. Dr Hubner's clinical interests include systemic chemotherapies, antibody therapies, and biological therapies for cancers of the oesophagus, stomach, pancreas, bile duct, gallbladder, primary liver and neuroendocrine system. He has a strong focus on research and is involved in a portfolio of clinical trials in both early and advanced cancer settings.
Dr Hubner is particularly interested in identification of factors which predict for efficacy and toxicity of chemotherapy and other systemic therapies, with the ultimate goal of personalised anti-cancer treatment. Dr Hubner has published over 30 original research articles, review articles, book chapters and meeting abstracts.